GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
53.71
+1.73 (3.33%)
At close: Jul 28, 2026, 4:00 PM EDT
54.00
+0.29 (0.54%)
After-hours: Jul 28, 2026, 7:59 PM EDT

GSK Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Equivalents
3,1053,4423,3973,2963,5994,4643,8703,1922,9622,7902,9363,1773,1402,8903,7233,6066,46510,9674,2743,453
Short-Term Investments
1191020212120211,3052,2463,5063,3644,0854,1543,555673,0106161
Cash & Short-Term Investments
3,1063,4433,4063,3063,6194,4853,8913,2122,9834,0955,1826,6836,5046,9757,8777,1616,53213,9774,3353,514
Cash Growth (YoY)
-14.17%-23.23%-12.46%2.93%21.32%9.52%-24.91%-51.94%-54.14%-41.29%-34.21%-6.68%-0.43%-50.10%81.71%103.78%83.38%190.16%-31.95%-19.51%
Accounts Receivable
7,7067,7567,4717,9377,3217,0596,8367,3837,2596,8317,3858,5446,7766,8337,0537,5086,4578,3007,8607,697
Other Receivables
368181288367376442489484519460373330319296405586413497486587
Total Trade Receivables
8,0747,9377,7598,3047,6977,5017,3257,8677,7787,2917,7588,8747,0957,1297,4588,0946,8708,7978,3468,284
Inventory
6,2826,1575,9246,1186,0726,0005,6695,9185,8595,7025,4985,4805,5125,3555,1464,6594,6646,0035,7836,244
Other Current Assets
972244211142859911230114411720620323726028833536,122211210212
Total Current Assets
17,55917,76117,51017,84217,67318,08516,99717,29816,76417,20518,64421,24019,34819,71920,76920,24954,18828,98818,67418,254
Net Property, Plant & Equipment
10,03210,03810,04810,1329,9189,97110,0739,7259,8239,8679,9579,4549,3159,4149,6209,6509,15310,70410,67210,667
Other Intangible Assets
16,80218,13816,74816,86515,37616,25815,51515,01015,47315,66714,76815,29515,53114,16014,31815,58911,37130,46830,07930,241
Goodwill
7,3817,2877,0187,1176,7346,9266,9826,6806,9606,9786,8116,9736,7166,8577,0467,1955,90610,70510,55210,582
Long-Term Investments
9559581,1261,0839771,0321,1961,1041,1521,2771,1921,1421,3501,3401,5411,6301,7281,7392,2142,818
Other Long-Term Assets
9,0098,6878,6688,3008,5808,4338,7008,2327,8947,5177,6336,7587,2017,1066,8526,0006,6997,0856,9126,127
Total Assets
61,73862,86961,11861,33959,25860,70559,46358,04958,06658,51159,00560,86259,46158,59660,14660,31389,04589,68979,10378,689
Accounts Payable
14,34214,33515,38115,67514,82015,14915,33514,37514,24514,62115,84415,58213,95114,26816,26316,11514,80617,57717,55415,230
Current Portion of Long-Term Debt
4,2915,0443,0122,8562,0501,9582,3492,8153,3662,6162,8134,8435,9214,2613,9522,7933,3274,1023,6014,869
Other Current Liabilities
2,9013,0502,9982,8033,5083,7244,0134,2692,7342,6092,4111,9652,2362,1672,5952,04519,7022,5992,5152,318
Total Current Liabilities
21,53422,42921,39121,33420,37820,83121,69721,45920,34519,84621,06822,39022,10820,69622,81020,95337,83524,27823,67022,417
Long-Term Debt
13,94714,01214,70814,89415,30416,47414,63713,24413,57715,15615,20515,99315,55316,64417,03519,32218,78429,22620,57220,736
Other Long-Term Liabilities
9,0809,0069,0639,3599,2229,74610,0439,89310,37410,2809,9379,8609,6419,94410,20511,3229,78613,55313,51913,788
Total Long-Term Liabilities
23,02723,01823,77124,25324,52626,22024,68023,13723,95125,43625,14225,85325,19426,58827,24030,64428,57042,77934,09134,524
Total Liabilities
44,56145,44745,16245,58744,90447,05146,37744,59644,29645,28246,21048,24347,30247,28450,05051,59766,40567,05757,76156,941
Common Stock
1,3491,3491,3491,3491,3491,3491,3481,3481,3481,3481,3481,3481,3481,3481,3471,3471,3471,347-1,347
Additional Paid-in Capital
3,5073,5063,4983,4863,4863,4843,4733,4733,4723,4713,4513,4503,4503,4493,4403,4403,4393,436-3,300
Accumulated Other Comprehensive Income
1,3251,4071,3211,2971,1591,0171,0541,0009691,0861,3091,3181,4751,3681,4481,7731,7641,761-2,996
Retained Earnings
11,46411,59010,20910,0168,7978,3077,7968,1878,5837,9357,2397,0176,4185,6554,3632,5929,8249,637-7,783
Total Common Shareholders' Equity
17,64517,85216,37716,14814,79114,15713,67114,00814,37213,84013,34713,13312,69111,82010,5989,15216,37416,181-15,426
Minority Interest
-468-430-421-396-437-503-585-555-602-611-552-514-532-508-502-4366,2666,451-6,322
Shareholders' Equity
17,17717,42215,95615,75214,35413,65413,08613,45313,77013,22912,79512,61912,15911,31210,0968,71622,64022,63221,34221,748
Total Liabilities & Equity
61,73862,86961,11861,33959,25860,70559,46358,04958,06658,51159,00560,86259,46158,59660,14660,31389,04589,68979,10378,689
Total Debt
18,23819,05617,72017,75017,35418,43216,98616,05916,94317,77218,01820,83621,47420,90520,98722,11522,11133,32824,17325,605
Net Cash (Debt)
-15,132-15,613-14,314-14,444-13,735-13,947-13,095-12,847-13,960-13,677-12,836-14,153-14,970-13,930-13,110-14,954-15,579-19,351-19,838-22,091
Net Cash Growth (YoY)
--------------------
Net Cash Per Share
-7.45-7.67-7.01-7.04-6.68-6.74-6.32-6.21-6.77-6.65-6.24-6.88-7.32-6.82-6.41-7.32-7.67-9.52-9.78-10.90
Book Value
17,64517,85216,37716,14814,79114,15713,67114,00814,37213,84013,34713,13312,69111,82010,5989,15216,37416,181015,426
Book Value Per Share
8.698.768.027.877.206.846.606.776.976.736.496.396.205.795.184.488.067.96-7.61
Tangible Book Value
-6,538-7,573-7,389-7,834-7,319-9,027-8,826-7,682-8,061-8,805-8,232-9,135-9,556-9,197-10,766-13,632-903-24,992-40,631-25,397
Tangible Book Value Per Share
-3.22-3.72-3.62-3.82-3.56-4.36-4.26-3.71-3.91-4.28-4.00-4.44-4.67-4.50-5.26-6.67-0.44-12.29-20.03-12.53
SEC Filings: 10-K · 10-Q